Korea Investment Corp Neurocrine Biosciences Inc Transaction History

Korea Investment Corp

$41.3 Billion
Q3 2024

A detailed history of Korea Investment Corp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Korea Investment Corp holds 66,189 shares of NBIX stock, worth $8.31 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

66,189

Previous 107,477 38.42%

Holding current value

$8.31 Million

Previous $14.8 Million 48.5%

% of portfolio

0.02%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$114.58 - $153.15 $4.73 Million - $6.32 Million	-41,288 Reduced 38.42%	66,189 $7.62 Million
Q2 2024 Aug 13, 2024	BUY	$130.86 - $143.19 $9.08 Million - $9.93 Million	69,372 Added 182.05%	107,477 $14.8 Million
Q1 2024 May 14, 2024	SELL	$130.4 - $143.74 $5.91 Million - $6.51 Million	-45,324 Reduced 54.33%	38,105 $5.26 Million
Q4 2023 Feb 13, 2024	BUY	$106.07 - $132.76 $5.12 Million - $6.41 Million	48,280 Added 137.36%	83,429 $11 Million
Q3 2023 Nov 13, 2023	BUY	$94.02 - $117.1 $1.86 Million - $2.31 Million	19,768 Added 128.52%	35,149 $3.95 Million
Q2 2023 Aug 11, 2023	SELL	$89.53 - $104.87 $104,302 - $122,173	-1,165 Reduced 7.04%	15,381 $1.45 Million
Q1 2023 May 12, 2023	SELL	$94.11 - $123.02 $176,832 - $231,154	-1,879 Reduced 10.2%	16,546 $1.67 Million
Q4 2022 Feb 13, 2023	BUY	$106.72 - $127.06 $340,009 - $404,813	3,186 Added 20.91%	18,425 $2.2 Million
Q3 2022 Nov 10, 2022	BUY	$92.03 - $107.81 $745,350 - $873,153	8,099 Added 113.43%	15,239 $1.62 Million
Q2 2022 Aug 12, 2022	BUY	$75.79 - $100.07 $541,140 - $714,499	7,140 New	7,140 $696,000
Q3 2021 Nov 12, 2021	SELL	$86.18 - $99.03 $189,596 - $217,866	-2,200 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$89.43 - $102.27 $17,886 - $20,454	-200 Reduced 8.33%	2,200 $214,000
Q1 2021 May 13, 2021	SELL	$87.57 - $119.4 $2.06 Million - $2.81 Million	-23,500 Reduced 90.73%	2,400 $233,000
Q4 2020 Feb 10, 2021	BUY	$86.91 - $108.33 $139,056 - $173,328	1,600 Added 6.58%	25,900 $2.48 Million
Q3 2020 Nov 12, 2020	BUY	$96.16 - $135.15 $96,160 - $135,150	1,000 Added 4.29%	24,300 $2.34 Million
Q2 2020 Aug 12, 2020	BUY	$85.09 - $130.36 $119,126 - $182,504	1,400 Added 6.39%	23,300 $2.84 Million
Q1 2020 May 14, 2020	BUY	$75.11 - $113.76 $1.64 Million - $2.49 Million	21,900 New	21,900 $1.9 Million

Others Institutions Holding NBIX

# of Institutions

629

Shares Held

94.2M

Call Options Held

692K

Put Options Held

406K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.

Account

Korea Investment Corp Neurocrine Biosciences Inc Transaction History